Though they seem rare, kids’ cancers have a huge impact; cancer is the second-leading cause of death among children, after accidents. Yet very few new drugs are developed specifically for kids’ cancers; most drugs used for childhood cancer aren’t approved for use in kids. Stephen Sallan, professor of pediatrics at Dana-Farber Cancer Institute, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?